- Home
- GRX vs THTX Comparison
GRX vs THTX Comparison
Compare GRX & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- THTX
- Stock Information
- Founded
- GRX 2007
- THTX 1993
- Country
- GRX United States
- THTX Canada
- Employees
- GRX N/A
- THTX N/A
- Industry
- GRX Finance/Investors Services
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- THTX Health Care
- Exchange
- GRX Nasdaq
- THTX Nasdaq
- Market Cap
- GRX 145.5M
- THTX 144.8M
- IPO Year
- GRX N/A
- THTX N/A
- Fundamental
- Price
- GRX $9.16
- THTX $3.31
- Analyst Decision
- GRX
- THTX Hold
- Analyst Count
- GRX 0
- THTX 1
- Target Price
- GRX N/A
- THTX N/A
- AVG Volume (30 Days)
- GRX 39.7K
- THTX 530.3K
- Earning Date
- GRX 01-01-0001
- THTX 10-09-2025
- Dividend Yield
- GRX 5.98%
- THTX N/A
- EPS Growth
- GRX N/A
- THTX N/A
- EPS
- GRX 0.26
- THTX N/A
- Revenue
- GRX N/A
- THTX $84,378,000.00
- Revenue This Year
- GRX N/A
- THTX N/A
- Revenue Next Year
- GRX N/A
- THTX $13.76
- P/E Ratio
- GRX $38.50
- THTX N/A
- Revenue Growth
- GRX N/A
- THTX 2.19
- 52 Week Low
- GRX $7.73
- THTX $1.12
- 52 Week High
- GRX $10.40
- THTX $3.34
- Technical
- Relative Strength Index (RSI)
- GRX 33.40
- THTX 74.01
- Support Level
- GRX $9.33
- THTX $3.26
- Resistance Level
- GRX $9.22
- THTX $3.34
- Average True Range (ATR)
- GRX 0.08
- THTX 0.02
- MACD
- GRX -0.04
- THTX -0.00
- Stochastic Oscillator
- GRX 2.27
- THTX 70.00
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.